Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 172

Работа: Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms

  1. Disorders of cancer metabolism: The therapeutic potential of cannabinoids

    Dingya Sun, Xin Li, Shengdan Nie +2

    Обзорная статья2022Цитирований: 9
    ABI

  2. Tumor Cell-Targeting and Tumor Microenvironment–Responsive Nanoplatforms for the Multimodal Imaging-Guided Photodynamic/Photothermal/Chemodynamic Treatment of Cervical Cancer

    Ying Wang, Yiyan Xu, Jiayu Song +8

    Статья2024Цитирований: 8
    ABI

  3. <scp>CHB</scp> patients with <scp>rtA181T</scp>‐mutated <scp>HBV</scp> infection are associated with higher risk hepatocellular carcinoma due to increases in mutation rates of tumour suppressor genes

    Qiqi Ning, Tongwang Yang, Xianghua Guo +8

    Статья2023Цитирований: 8
    ABI

  4. Neoantigens: promising targets for cancer therapy

    Na Xie, Guobo Shen, Wei Gao +3

    Обзорная статья2023Цитирований: 6
    ABI

  5. A <scp>TGF</scp>‐β signaling‐related <scp>lncRNA</scp> signature for prediction of glioma prognosis, immune microenvironment, and immunotherapy response

    Weiwei Duan, Liting Yang, Jian Liu +13

    Статья2023Цитирований: 6
    ABI

  6. Exploring treatment options in cancer: tumor treatment strategies

    Beilei Liu, Hongyu Zhou, Licheng Tan +2

    Обзорная статья2024Цитирований: 5
    ABI

  7. Simultaneous quantification of mirabegron and vibegron in human plasma by HPLC-MS/MS and its application in the clinical determination in patients with tumors associated with overactive bladder

    Yutao Lou, Mengting Cheng, Qin Cao +7

    Статья2023Цитирований: 5
    ABI

  8. Immunotherapy and the ovarian cancer microenvironment: Exploring potential strategies for enhanced treatment efficacy

    Zhibin Wang, Xiu Zhang, Chao Fang +4

    Обзорная статья2024Цитирований: 4
    ABI

  9. A multi-omics approach to reveal critical mechanisms of activator protein 1 (AP-1)

    Fei Li, Jiaqi Tian, Lin Zhang +2

    Обзорная статья2024Цитирований: 4
    ABI

  10. Alantolactone: structural enhancements and therapeutic insights for cancer and inflammation

    Muzaffar Kayumov, Fotima A. Sobirova, Okhunjon Khasanov +3

    Обзорная статьяSesquiterpenes and Asteraceae StudiesNatural Product Research2025Цитирований: 3
    ABI

  11. Innovation networks in the advanced medical equipment industry: supporting regional digital health systems from a local–national perspective

    Feng Hu, Huijie Yang, Liping Qiu +6

    Статья2025Цитирований: 3
    ABI

  12. Targeted protein degradation via the autophagy-lysosome system: AUTOTAC (AUTOphagy-TArgeting Chimera)

    Chang Hoon Ji, Min Ju Lee, Hee Yeon Kim +5

    Другое2022Цитирований: 3
    ABI

  13. Co-Crystallization Approach to Enhance the Stability of Moisture-Sensitive Drugs

    Madhukiran R. Dhondale, Pradip Thakor, Amritha G. Nambiar +4

    Обзорная статья2023Цитирований: 2
    ABI

  14. The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients

    Jill Hallin, Lars D. Engstrom, Lauren Hargis +31

    Статья2019Цитирований: 2
    ABI

  15. A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo

    Longchuan Bai, Haibin Zhou, Renqi Xu +15

    Статья2019Цитирований: 2
    ABI

  16. Protac-Induced Protein Degradation in Drug Discovery: Breaking the Rules or Just Making New Ones?

    Ian Churcher

    Обзорная статья2017Цитирований: 2
    ABI

  17. AUTACs: Cargo-Specific Degraders Using Selective Autophagy

    Daiki Takahashi, Jun Moriyama, Tomoe Y. Nakamura +6

    Статья2019Цитирований: 2
    ABI

  18. Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance

    Xin Lin, Hua Xiang, Guoshun Luo

    Обзорная статья2020Цитирований: 2
    ABI

  19. Development of Antibody-Based PROTACs for the Degradation of the Cell-Surface Immune Checkpoint Protein PD-L1

    Adam D. Cotton, Duy Nguyen, Josef A. Gramespacher +2

    Статья2021Цитирований: 2
    ABI

  20. Covalently Engineered Nanobody Chimeras for Targeted Membrane Protein Degradation

    Heng Zhang, Yu Han, Yuanfan Yang +7

    Статья2021Цитирований: 2
    ABI

  21. PROTAC targeted protein degraders: the past is prologue

    Miklós Békés, David R. Langley, Craig M. Crews

    Обзорная статья2022Цитирований: 2
    ABI

  22. Proteolysis-targeting chimeras (PROTACs) in cancer therapy

    Xinyi Li, Wenchen Pu, Qingquan Zheng +3

    Статья2022Цитирований: 2
    ABI

  23. Molecular Glues: Capable Protein-Binding Small Molecules That Can Change Protein–Protein Interactions and Interactomes for the Potential Treatment of Human Cancer and Neurodegenerative Diseases

    Fengzhi Li, Ieman Aljahdali, Xiang Ling

    Обзорная статья2022Цитирований: 2
    ABI

  24. Targeted Protein Degradation via Lysosomes

    Rishi R. Paudel, Dong Lu, Sandipan Chowdhury +2

    Обзорная статья2022Цитирований: 2
    ABI

  25. Targeted Protein Degradation: Clinical Advances in the Field of Oncology

    Abdelrahman K. A. A. Salama, Marija V. Trkulja, Emilio Casanova +1

    Обзорная статья2022Цитирований: 2
    ABI